Traditional PCOS classification systems, such as the Rotterdam and NIH criteria, primarily rely on clinical manifestations—hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology—combined with biochemical indicators including serum androgen levels, fasting insulin concentrations, HOMA-IR values, and dyslipidaemia [198]. Here, INS is linked to hyperandrogenism.